David Cohen, MD
Thoracic Surgery (Cardiothoracic Vascular Surgery) · Lebanon, PANPI 1861499337
Payments from drug & device makers
Across 39 payments — averaging $102.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Guard Medical Inc.$2K
- Abbott$1K
- Convatec Inc.$257
- Janssen Scientific Affairs, LLC$125
- Paratek Pharmaceuticals, Inc.$125
- Smith+Nephew$61
- plus $232 from 9 others
What the payments were for
- Consulting fees$2,00050%
- Travel & lodging$78320%
- Food & beverage$1,21030%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Guard Medical Inc. | 1 | $2,000 |
| Abbott | 8 | $1,192 |
| Convatec Inc. | 15 | $257 |
| Janssen Scientific Affairs, LLC | 1 | $125 |
| Paratek Pharmaceuticals, Inc. | 1 | $125 |
| Smith+Nephew | 3 | $61 |
| Atricure, Inc. | 1 | $58 |
| Edwards Lifesciences | 1 | $36 |
| Esperion Therapeutics, Inc. | 2 | $33 |
| AstraZeneca | 1 | $22 |
| Solventum Corporation | 1 | $20 |
| Hydrofera LLC | 1 | $19 |
| Hartmann USA, Inc. | 1 | $17 |
| Integra Lifesciences Corporation | 1 | $14 |
| Reprise Biomedical, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NPSEAL LARGE$2,000
- MitraClip$900
- XARELTO$125
- NUZYRA$125
How this compares
$3,993 in reported general payments places this provider in the 40th percentile of 314 thoracic surgery (cardiothoracic vascular surgery) providers in Pennsylvania.
See all thoracic surgery (cardiothoracic vascular surgery) providers in Pennsylvania →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Silver Sulfadiazine | 13 | $198 |
| Mupirocin | 15 | $186 |
Paid to pharmacies, not to this prescriber.
Other thoracic surgery (cardiothoracic vascular surgery) in Lebanon
- Joseph BavariaAllentown$6.6M
- Mubashir MumtazHarrisburg$5M
- Basel RamlawiWynnewood$4.4M
- Ibrahim SultanPgh.$2.9M
- Nimesh DesaiPhiladelphia$1.6M
- Benny WekslerPittsburgh$1.5M
- Stephen BaileyPittsburgh$1.3M
- Scott GoldmanWynnewood$1.1M
- Wilson SzetoPhiladelphia$1.1M
- Patrick RossWynnewood$956K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.